Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant

NCT01687270 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Chronic Hepatitis C Virus
Post Liver Transplant

Interventions

DRUG: Sofosbuvir
DRUG: RBV

Sponsor

Gilead Sciences